References
Hacioglu A, Borekci S, Melikoglu M et al (2021) Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates. Rheumatol Int. https://doi.org/10.1007/s00296-021-04926-z (Online ahead of print)
Taxonera C, Ponferrada Á, Bermejo F, SEGURTB study group from GETECCU et al (2017) Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory bowel disease. J Crohns Colitis 11:792–800. https://doi.org/10.1093/ecco-jcc/jjx022
Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57(9):804–809. https://doi.org/10.1136/thorax.57.9.804
Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11):1192–1204
Piñeiro R, Mellado MJ, Cilleruelo MJ et al (2012) Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 171:1625–1632. https://doi.org/10.1007/s00431-012-1783-8
Seddon JA, Paton J, Nademi Z et al (2016) The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax 71(10):932–939. https://doi.org/10.1136/thoraxjnl-2015-207687
World Health Organization (2014) Guidance for national tuberculosis programme on the management of tuberculosis in children (second edition). Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf?ua=1. Accessed 25 Jul 2021
National Institute for Health and Care Excellence. Tuberculosis NICE guideline Published: 13 January 2016. http://www.nice.org.uk/guidance/ng33/resources/tuberculosis-prevention-diagnosis-management-and-service-organisation-1837390683589. Accessed 2 Aug 2021
Berti E, Galli L, Venturini E et al (2014) Tuberculosis in childhood: a systematic review of national and international guidelines. BMC Infect Dis 14(Suppl 1):S3. https://doi.org/10.1186/1471-2334-14-S1-S3
Riestra S, Taxonera C, Zabana Y et al (2021) Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease. Gastroenterol Hepatol 44(1):51–66. https://doi.org/10.1016/j.gastrohep.2020.04.006
Funding
The article received no specific funding.
Author information
Authors and Affiliations
Contributions
CT, DO, and CA wrote the paper.
Corresponding author
Ethics declarations
Conflict of interest
CT has served as a speaker, consultant, and advisory board member for MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, and Tillots. CA has served as a speaker for Janssen and has prepared promotional material for Falk Pharma. DO has no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Taxonera, C., Olivares, D. & Alba, C. Recommendations for the detection of latent tuberculosis infection in patients with immune-mediated inflammatory diseases candidates for anti-TNF therapy may not be applicable in all settings. Rheumatol Int 42, 1491–1492 (2022). https://doi.org/10.1007/s00296-021-04963-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04963-8